Clinical trials - Press Releases

Date	Title	Company
23-Feb-2022	Results from an Ongoing Phase I/II CYPIDES Trial of ODM-208 Presented at ASCO-GU	Orion Corporation
22-Feb-2022	Europe’s Only Parallel Trade Conference returns for its 16th Year	SMi Group
22-Feb-2022	NICE Recommends Albireo’s Bylvay®(odevixibat) for All PFIC Types	Albireo Pharma Inc
18-Feb-2022	Darolutamide shows significant increase in overall survival and decrease in disease progression in men with metastatic hormone-sensitive prostate cancer	Bayer
17-Feb-2022	Albireo Announces Publication of the PICTURE Study Highlighting the Caregiver Impact of PFIC, a Rare and Devastating Children’s Liver Disease	Albireo Pharma Inc.
15-Feb-2022	ProQR Announces Top-Line Results from Phase 2/3 Illuminate Trial of Sepofarsen in CEP290-mediated LCA10	ProQR Therapeutics N.V.
15-Feb-2022	Oxurion Announces New Data on THR-149 Phase 2 Clinical Trial (“KALAHARI”) in DME at the Angiogenesis, Exudation, and Degeneration 2022 Conference	Oxurion NV
15-Feb-2022	mdgroup Appoints Steph Katz as Director of Seacole Health	mdgroup
15-Feb-2022	Velocity Clinical Research makes tech investments to strengthen patient and client engagement in clinical trials	Velocity Clinical Research
15-Feb-2022	Medidata Opens Access to its Patient Insights Program, Enabling Sponsors and CROs to Leverage Proprietary Patient Centricity by Design Process for Clinical Trials	Medidata
15-Feb-2022	Janssen Presents New Data Demonstrating the Combination of Niraparib and Abiraterone Acetate Plus Prednisone Significantly Improved Radiographic Progression-Free Survival as a First-Line Therapy in Patients with HRR Gene-Mutated Metastatic Castration-Resistant Prostate Cancer	The Janssen Pharmaceutical Companies of Johnson & Johnson
14-Feb-2022	mdgroup Listed Among the UK’s Fastest-Scaling Firms in Organic Growth 25 Index	mdgroup
11-Feb-2022	Emmes Supports New Collaboration to Accelerate COVID-19 Research for Children	Emmes
11-Feb-2022	Oxurion Announces Upcoming Presentation on THR-149 Phase 2 Clinical Trial (“KALAHARI”) at the Angiogenesis, Exudation, and Degeneration 2022 Conference	Oxurion
09-Feb-2022	Book to attend the Parallel Trade conference before seats are filled	SMi Group
09-Feb-2022	Novotech Recognized as Top 10 CRO in CenterWatch Site Relationship Benchmarking Report	Novotech
08-Feb-2022	Cytovation collaborates with Recurrent Respiratory Papillomatosis Foundation to expand its clinical investigations of CyPep-1 into rare neoplastic disease	Cytovation
08-Feb-2022	AlzeCure is moving towards Phase IIa clinical trial with ACD440 based on guiding response from the FDA	AlzeCure Pharma AB
08-Feb-2022	vasopharm GmbH Announces Post Hoc Analyses of Clinical Trials in Traumatic Brain Injury	vasopharm GmbH
08-Feb-2022	Cytovation collaborates with Recurrent Respiratory Papillomatosis Foundation to expand its clinical investigations of CyPep-1 into rare neoplastic disease	Cytovation AS